PAVmed (NASDAQ:PAVM) Shares Cross Below 50 Day Moving Average – Time to Sell?

PAVmed Inc. (NASDAQ:PAVM) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.19 and traded as low as $1.05. PAVmed shares last traded at $1.05, with a volume of 17,961 shares changing hands.

Analysts Set New Price Targets

Separately, Ascendiant Capital Markets dropped their target price on PAVmed from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Tuesday, September 10th.

PAVmed Stock Down 4.0 %

The stock has a market cap of $10.69 million, a PE ratio of -0.13 and a beta of 0.68. The stock has a 50-day moving average of $1.20 and a 200 day moving average of $1.24.

PAVmed (NASDAQ:PAVM) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.84) earnings per share (EPS) for the quarter. The business had revenue of $0.98 million during the quarter. On average, equities analysts anticipate that PAVmed Inc. will post -5.17 EPS for the current year.

PAVmed Company Profile

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.